CLDX
CLDX
NASDAQ · Biotechnology

Celldex Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$32.98
-0.43 (-1.29%)
Analyst Consensus
Strong Buy
22
Analysts
High
Coverage
Buy 20 91%
Hold 2 9%
Sell 0 0%
Price Target
Analyst Price Target +57.9% upside
Low Target $39.61
Average Target $52.08
High Target $81.09
Current Price $32.98
Current
$32.98
Target
$52.08
$39.61 $52.08 avg $81.09
Scenario Analysis
Bear Case
$39.61
20.1%
Low target
Base Case
$52.08
+57.9%
Avg target
Bull Case
$81.09
+145.9%
High target
Risk/Reward
7.3x
Highly favorable
Price in Context
52-Week High
$35.79
-7.9% from high
52-Week Low
$19.52
+69.0% from low
Target vs 52W High
$52.08
+45.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +9.7%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -45.0%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +190.0%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -6.4%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.6%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -64.5%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -32.7%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -39.1%